Hilary A Coller

Title: Hilary A Coller: Innovator in Chemosensitivity Prediction

Introduction

Hilary A Coller is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of biomedical research, particularly in the area of predicting chemosensitivity and chemoresistance. His work has the potential to greatly impact cancer treatment and patient outcomes.

Latest Patents

Hilary A Coller holds 1 patent titled "Methods for predicting chemosensitivity or chemoresistance." This patent describes methods and apparatus for classifying or predicting the classes for samples based on gene expression. It also includes methods for discovering new, previously unknown classes based on gene expression. The classification occurs through the analysis of gene expression data from samples that have been subjected to one or more compounds, determining whether a sample is treatment sensitive or resistant.

Career Highlights

Throughout his career, Hilary has worked with esteemed institutions such as the Whitehead Institute for Biomedical Research and Dana-Farber Cancer Institute. His research has focused on advancing the understanding of how gene expression can influence treatment responses in cancer patients.

Collaborations

Hilary A Coller has collaborated with notable colleagues, including Pablo Tamayo and Jane E Staunton. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field of cancer treatment.

Conclusion

Hilary A Coller is a key figure in the realm of biomedical innovation, particularly in the prediction of chemosensitivity and chemoresistance. His contributions are paving the way for more effective cancer treatments and improved patient care.